Radhika Gangaraju

Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini et al. · Journal of the National Comprehensive Cancer Network · 2024 · 143 citations

Cancer Management, Pharmacotherapy, Cancer-associated Vte +17

Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia

Radhika Gangaraju, Jihyun Song, Soo Jin Kim et al. · Blood Advances · 2020 · 76 citations · Full text

Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

Elizabeth M. Staley, Wenjing Cao, Huy P. Pham et al. · Haematologica · 2018 · 74 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +21

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Tzu‐Fei Wang, Lisa Baumann Kreuziger, Avi Leader et al. · Journal of Thrombosis and Haemostasis · 2021 · 36 citations · Full text

Isth Ssc Subcommittee, Thrombosis, Venous Thrombosis +9

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura

Jingrui Sui, Wenjing Cao, Konstantine Halkidis et al. · Blood Advances · 2019 · 34 citations · Full text

Immunology, Pathology, Longitudinal Assessments +18